Search Results - "Slakey LM"

Molecular Mechanisms of Symptom Fluctuations in Malignant Tumor Patients: Stable by Day and Severe at Night.

Authors: Xie, Zhongxuan Jin, Wei Pang, Juezhou et al.

Source: Journal of Cancer. 2026, Vol. 17 Issue 3, p571-582. 12p.

Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors: Vaziri, Nima Shakourifar, Melika Sattari, Parinaz et al.

Source: IJ Pharmaceutical Research (IJPR). Dec2024, Vol. 23 Issue 1, p1-12. 12p.

Nomogram and a predictive model for postoperative hemorrhage in preoperative patients of laparoscopic pancreaticoduodectomy.

Authors: Li, Dongrui Du, Chengxu Zhang, Jiansheng et al.

Source: Scientific Reports. 7/20/2021, Vol. 11 Issue 1, p1-7. 7p.

The regulatory role of melatonin in pituitary thyroid-stimulating hormone synthesis through casein kinase 1α.

Authors: BINGJIE WANG YEWEN ZHOU TONGJUAN NIU et al.

Source: Biocell. 2024, Vol. 48 Issue 2, p327-338. 12p.

Melatonin Mitigates the Progression of Chemically Induced Hepatocellular Carcinoma in Rats via Targeting Wnt/B-Catenin Pathway, and Small Noncoding miR-let-7b.

Authors: Eldeen, Nesma Mohammed Bahaa Kamel, Moataz Maher Mohamed, Abbas et al.

Source: Reports of Biochemistry & Molecular Biology. Oct2023, Vol. 12 Issue 3, p403-414. 12p.

Melatonin: Avenues in cancer therapy and its nanotechnological advancements.

Authors: Putta, Chandra Lekha Eswar, Kalyani Rengan, Aravind Kumar

Source: Medcomm: Biomaterials & Applications. Sep2023, Vol. 2 Issue 3, p1-30. 30p.

Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells.

Authors: Hasan, Mahmud Browne, Erin Guarinoni, Laura et al.

Source: Breast Cancer: Basic & Clinical Research. 6/24/2020, Vol. 14, p1-12. 12p. 1 Diagram, 2 Charts, 5 Graphs.

Interactions of melatonin with various signaling pathways: implications for cancer therapy.

Authors: Mihanfar, Ainaz Yousefi, Bahman Azizzadeh, Bita et al.

Source: Cancer Cell International. 12/29/2022, Vol. 22 Issue 1, p1-18. 18p.

Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence.

Authors: Moradian, Farid Pourhanifeh, Mohammad Hossein Mehrzadi, Saeed et al.

Source: Fundamental & Clinical Pharmacology. Oct2022, Vol. 36 Issue 5, p777-789. 13p.

Metabolic landscapes in sarcomas.

Authors: Miallot, Richard Galland, Franck Millet, Virginie et al.

Source: Journal of Hematology & Oncology. 7/22/2021, Vol. 14 Issue 1, p1-23. 23p.

Role and Therapeutic Potential of Melatonin in Various Type of Cancers.

Authors: Gurunathan, Sangiliyandi Qasim, Muhammad Kang, Min-Hee et al.

Source: OncoTargets & Therapy. Mar2021, Vol. 14, p2019-2052. 34p.

Melatonin abrogates liver, ovarian, and uterine toxicities induced by tamoxifen in a breast cancer mouse model.

Authors: Alanazy, Iman Ali aldahmash, Badr El-Nagar, Doaa Mohamed et al.

Source: Indian Journal of Experimental Biology. Jan2021, Vol. 59 Issue 1, p33-43. 11p.

Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901.

Authors: Zhang, S Qi, Y Zhang, H et al.

Source: Biotechnic & Histochemistry. Aug2013, Vol. 88 Issue 6, p281-289. 9p. 2 Color Photographs, 4 Charts, 6 Graphs.

Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis.

Authors: Hosseinzadeh A Pourhanifeh MH Amiri S et al.

Source: Pharmacological reports : PR [Pharmacol Rep] 2024 Feb; Vol. 76 (1), pp. 25-50. Date of Electronic Publication: 2023 Nov 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2299-5684 (Electronic) Linking ISSN: 17341140 NLM ISO Abbreviation: Pharmacol Rep Subsets: MEDLINE

Melatonin: does it have utility in the treatment of haematological neoplasms?

Authors: Li, Tian Yang, Zhi Jiang, Shuai et al.

Source: British Journal of Pharmacology. Aug2018, Vol. 175 Issue 16, p3251-3262. 12p. 2 Diagrams, 2 Charts.

Increase in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation.

Authors: Proietti, Sara Catizone, Angela Masiello, Maria Grazia et al.

Source: Journal of Pineal Research. May2018, Vol. 64 Issue 4, p1-1. 17p.

Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets and laptops at night.

Authors: Mortazavi, Seyed Ali Reza Mortazavi, Seyed Mohammad Javad

Source: Iranian Journal of Basic Medical Sciences. Feb2018, Vol. 21 Issue 2, p112-115. 4p.

Melatonin inhibits colon cancer RKO cell migration by downregulating Rho-associated protein kinase expression via the p38/MAPK signaling pathway.

Authors: ZHEN LIU DUOBING ZOU XIAOPING YANG et al.

Source: Molecular Medicine Reports. Dec2017, Vol. 16 Issue 6, p9383-9392. 10p.

Osteoprotegerin mediates tumorpromoting effects of Interleukin-1beta in breast cancer cells.

Authors: Stephanie Tsang Mui Chung Geerts, Dirk Roseman, Kim et al.

Source: Molecular Cancer. 2/1/2017, Vol. 16, p1-14. 14p. 2 Charts, 6 Graphs.

Cancer metastasis: Mechanisms of inhibition by melatonin.

Authors: Su, Shih‐Chi Hsieh, Ming‐Ju Yang, Wei‐En et al.

Source: Journal of Pineal Research. Jan2017, Vol. 62 Issue 1, pn/a-N.PAG. 11p.